000 01484 a2200433 4500
005 20250516052305.0
264 0 _c20120103
008 201201s 0 0 eng d
022 _a1520-4804
024 7 _a10.1021/jm200584g
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLaplante, Steven R
245 0 0 _aAssessing atropisomer axial chirality in drug discovery and development.
_h[electronic resource]
260 _bJournal of medicinal chemistry
_cOct 2011
300 _a7005-22 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAmides
_xchemistry
650 0 4 _aDrug Discovery
650 0 4 _aHeterocyclic Compounds, 4 or More Rings
_xchemistry
650 0 4 _aLegislation, Drug
650 0 4 _aMacrocyclic Compounds
_xchemistry
650 0 4 _aModels, Molecular
650 0 4 _aPharmaceutical Preparations
_xchemistry
650 0 4 _aPharmacokinetics
650 0 4 _aStereoisomerism
650 0 4 _aStructure-Activity Relationship
650 0 4 _aThermodynamics
650 0 4 _aUnited States
650 0 4 _aUnited States Food and Drug Administration
700 1 _aD Fader, Lee
700 1 _aFandrick, Keith R
700 1 _aFandrick, Daniel R
700 1 _aHucke, Oliver
700 1 _aKemper, Ray
700 1 _aMiller, Stephen P F
700 1 _aEdwards, Paul J
773 0 _tJournal of medicinal chemistry
_gvol. 54
_gno. 20
_gp. 7005-22
856 4 0 _uhttps://doi.org/10.1021/jm200584g
_zAvailable from publisher's website
999 _c21091963
_d21091963